🎉 Congratulations to kyron.bio, winner of our Golden Ticket to Spartners by Servier & BioLabs France! kyron.bio is at the forefront of synthetic biology, developing advanced biomanufacturing processes for sustainable production. Their expertise lies in engineering microorganisms to produce high-value compounds, addressing global challenges in health, agriculture, and the environment with eco-friendly and cost-effective solutions. As a part of this year’s contest, kyron.bio will benefit from the latest research equipment, shared infrastructure, and numerous programs and services offered in Spartners by Servier & BioLabs. Learn more about Spartners by Servier & BioLabs France 👉 https://lnkd.in/eBa9FKzG #innovation #startup #biotech
Servier’s Post
More Relevant Posts
-
2023 National Award Biotechnology/President Biotech Companies Association (2020-23)/President ClosinGap Advisory Board | EU Market Access, Pricing, Government & Public Affairs and Health Executive | Sustainable Leader |
"Tearing up the traditional #biotech playbook": Interesting Editorial just published this month on Nature Biotechnology (#NatureBiotech), explaining that disruptive science today is more expensive and risky (10-15 years) and there is an imperative need for researchers and entrepreneurs to collaborate and have multidisciplinary teams. In order to improve collaboration a growing number of incubator, accelerator programs and innovation biohubs offer networking, support, and advice to early-stage and mid-stage companies, globally to accomplishing the high goal of curing diseases. https://lnkd.in/dbFYrniN https://lnkd.in/dhnsBrPY #biotech #innovation #HealthBiotech #biotecnología
To view or add a comment, sign in
-
Founder and CEO at ZYMVOL, entrepreneur, scientist, computational chemist, artist. EU Prize for Women Innovators 2020 winner.
🌱 Countdown to SynBioBeta 2024! 🌱 As SynBioBeta 2024 approaches, I'm reminded of a powerful statement from a past conference: "To show the world the importance of synthetic biology, we need to get more products to market!" 📍 Excited to be in San José for this inspiring event, I'm thrilled to share our latest strides at Oxyco. We're close to launching our first product—Melanin! Discover our groundbreaking work: www.oxyco.bio 🔬 But there's more brewing behind the scenes: ZYMSCAN: Our pioneering platform makes it easy for anyone to discover if a chemical transformation can be enzyme-driven. Check it out and see the possibilities: https://lnkd.in/dABicFhf BIOMATCHMAKER: Already know you need an enzyme? Our unique search platform boasts an over 80% success rate in finding novel enzymes tailored for specific needs. Explore here: https://lnkd.in/d9UaW4cK ZYMEVOLVER: For those looking to enhance an enzyme's performance for industrial applications, ZYMEVOLVER offers optimization of multiple properties, including activity, thermostability, selectivity, and specificity. Optimize your enzyme: https://lnkd.in/dnCxg-Wj 🌟 Join us as we push the boundaries of synthetic biology, transforming challenges into opportunities and innovations into realities. Looking forward to connecting with old friends and new faces at the conference! https://lnkd.in/d-WkQsEP #SynBioBeta2024 #SyntheticBiology #Innovation #Biotech #Startups #Science
To view or add a comment, sign in
-
𝐩𝐥𝐬 𝐬𝐡𝐚𝐫𝐞 - 𝐒𝐞𝐞𝐤𝐢𝐧𝐠 𝐆𝐞𝐫𝐦𝐚𝐧 𝐒𝐌𝐄 𝐏𝐚𝐫𝐭𝐧𝐞𝐫 𝐟𝐨𝐫 𝐄𝐮𝐫𝐨𝐬𝐭𝐚𝐫𝐬 𝐏𝐫𝐨𝐣𝐞𝐜𝐭 𝐨𝐧 𝐄𝐜𝐨-𝐅𝐫𝐢𝐞𝐧𝐝𝐥𝐲 𝐏𝐅𝐀𝐒 𝐒𝐮𝐛𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐬 Our goal at #BioHalo is to create sustainable #PFAS substitutes, and we are looking for a #German #SME to help us forge the path. Partner with us and Fraunhofer Institute for Interfacial Engineering and Biotechnology Michael Richter in a #Eurostars project aimed at creating biobased PFAS alternatives. Here’s the opportunity at a glance: ➡️Be part of a research consortium with up to €500,000 in grants. ➡️Tackle R&D activities up to Technology Readiness Level 6, with potential funding covering up to 50% of your project costs. ➡️Benefit from Zaz Ventures expertise in securing funding. We are focusing on sustainable production, process optimization, and the creation of initial prototypes of PFAS substitutes. We need a partner that is geared up for formulation development, upscaling, and refining processes right through to prototype production. Is there a German SME in your network that should be part of this exciting project? Tag them or send an email to nico@biohalo.io. Check out our project brief for more info: https://lnkd.in/eqM_wbaQ BioInnovation Institute, Petar Todorov, Arnoud Klokke, Mariela Mezzina, Pablo Ivan Nikel, Nicolas Krink, Johann Liebeton, Dr. Andreas Worberg, Martin Bellof, Britta Lange-Stolle, Holger Bengs, DECHEMA, CLIB - Cluster Industrielle Biotechnologie, chemstars.nrw, Tech Tour, BIO Deutschland e. V., Global Entrepreneurship Centre, Hello Tomorrow DTU Biosustain #Bioeconomy #Synbio #Biotechnology #LifeScience #PlanetaryHealth #Bioentrepreneurship #Startup #PFASReplacement #BioBasedMaterials #BioHalogenation #BioHalo #BioInnovationInstitute #BII #SustainableBiotech #Biopoylmers #PFAS #PHB
To view or add a comment, sign in
-
CCO and founder @EV Biotech | Finalist for EY's Emerging Entrepreneur of the Year 2023 | Board member Life Cooperative | Board member Holland Bio
I look forward to meeting real Industrial sustainability pioneers at World Bio Markets! Please reach out to me via LinkedIn or the event portal to chat about the possibilities of EV Biotech speeding up your time to market, increasing chances of developing a successful industrial fermentation process, and opening the black box of strain and fermentation engineering so you can make data-driven decisions in your development. #biotech #precisionfermentation #fermentation #biotechnology
🌟World Bio Markets, here we come! 🌟 We are pleased to share that Linda Dijkshoorn, our CCO and founder, will attend the World Bio Markets conference in The Hague. At EV Biotech, we are dedicated to driving innovation and sustainability in the biotech industry. By integrating advanced computational modeling with synthetic biology, we develop sustainable bioprocesses that contribute to a greener future. Our cutting-edge solutions and commitment to excellence set us apart in the industry. We invite all attendees of World Bio Markets to connect with Linda Dijkshoorn during the conference. This is a great opportunity to discuss industry insights, explore potential collaborations, and share ideas on advancing biotechnology. 🌍 Let’s work together to shape the future of biotech! 🌍 #WorldBioMarkets #Biotech #Sustainability #SyntheticBiology #ComputationalModeling #Networking #FutureOfBiotech #EVBiotech We look forward to an engaging and productive conference. You can contact Linda Dijkshoorn during the event or connect with her on LinkedIn. See you in The Hague! 🚀
To view or add a comment, sign in
-
Australia’s synthetic biology future is accelerating into overdrive — CSIRO and Main Sequence have today released an updated roadmap showcasing how SynBio could unlock over $30 billion in revenue and 50,000 new jobs in Australia by 2040. 💪 Looking back on Australia’s initial SynBio roadmap in 2021, the ecosystem has continued to evolve, welcoming new innovators, funding and support for the burgeoning sector, including: 🔬 A total of $44.5 million awarded for research projects related to synthetic biology ⭐ 16+ new synthetic biology-enabled start-ups and spin-outs created 💰 $363 million in capital investments raised by 17 Australian-founded synthetic biology companies Working with startups such as Cauldron Ferm, Samsara Eco and Uluu, we know that Australia’s SynBio industry represents a huge opportunity for our future, and this is only the beginning. Find the full report at the link in the comments to learn more. #SynBio #SyntheticBiology
To view or add a comment, sign in
-
🌟 Synbio Powerlabs, one of the key partners in the BIOCONNECT project driving forward the #development and #commercialization of #biotech #innovations. 🧬 Their mission is to catalyze the DNA-Economy, filling an industry gap by enabling the progression of disruptive biotechnologies from lab-scale experiments to large-scale applications. 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬: 🌟 With Europe's largest pilot facility and reactors up to 2 x 27,000L, Synbio Powerlabs is scaling up, preparing for even larger industrial-scale productions. 🔬 Offering an end-to-end suite of services, they boast facilities in Lappeenranta for piloting and an innovative R&D lab in Espoo, Finland. 🚀 Gearing up for a 2024 pilot launch with a versatile lineup of reactors (15L to 27,000L) and state-of-the-art downstream and pretreatment equipment. 💰 Their innovation journey is supported by a €3M grant from Business Finland and a significant €6.6M from their first funding. 🤝🏻 This collaboration underscores the commitment of both BIOCONNECT and Synbio Powerlabs to advance the field of biotechnology, ensuring impactful industry advancements and sustainable solutions. #BIOCONNECT #BIOCONNECTproject #collaboration #Synbio #Synbiopowerlabs #support #biotechnology #biotech #science #research #connection #innovation #startup
To view or add a comment, sign in
-
🔜 Next week, in Barcelona, #BIOSPAIN2023 will showcase the potential of the #biotech industry. The #BioRegion of Catalonia will have a strong presence both in the congress and the exhibition area! #Biocat, as a Regional Host of the event, is sponsoring and participating in the congress with a dozen sessions focused on trends in #health, advanced therapies, #biotech, #biomanufacturing and #healthdata, among others. But, you will also find the Catalan #biotech ecosystem in the exhibition area: ☑ More than 100 Catalan entities & companies will participate in the #fair ☑ 31 of these will attend with a #stand ☑ 10 #startups will have a #booth at the Pavilion of the BioRegion of Catalonia 🗣️ To Robert Fabregat Fuentes, CEO of #Biocat, the #BIOSPAIN2023 is a great opportunity to show the full potential of the #BioRegion, promote strategic connections and boost the positioning of Catalonia's BioRegion as an international reference ecosystem in the biotechnology sector. Read more here 📰👇 https://tuit.cat/Py8Mh AseBio - Asociación Española de Empresas Biotecnológicas, Ajuntament de Barcelona, Generalitat de Catalunya
To view or add a comment, sign in
-
Revolutionizing the Bio-Based Sector: Izote Biosciences' Fermentation Breakthrough In the realm of bio-based production, Izote Biosciences is charting a new course with its anaerobic fermentation technology. Co-founded by Victor Manuel Reyes-Umaña, a microbiologist, and Samuel Atwood, a former McKinsey & Company consultant, Izote has successfully closed an oversubscribed pre-seed funding round of $2.6 million, signaling strong market interest in their innovation. 🔬 The Innovation Edge: Izote's method allows bacteria to flourish without oxygen, using a molecule vastly more soluble than oxygen. This not only simplifies bioreactor design but also slashes operational costs, a game-changer for industries reliant on precision fermentation. 💡 Market Transformation: The implications for the fragrance, flavor, food, and cosmetics industries are profound. Izote's technology is set to deliver cost savings and boost gross margins, reshaping the economics of bio-based molecule production. Investment Potential: 💼 Cutting-Edge Appeal: Izote's pioneering approach is a magnet for investors looking to capitalize on the next wave of industrial biotech advancements. 💼 Scalability Meets Savings: With the promise of 70% lower capital expenditures and up to 100% higher gross margins, Izote's technology is poised for rapid market penetration and scalability. 💼 Confirmed Confidence: The success of Izote's pre-seed funding, led by top-tier venture capitalists, is a testament to the market's belief in their disruptive potential. Future Outlook: As Izote sets its sights on identifying launch molecules and proving scalability, the startup is well-positioned for sustainable growth and industry leadership. This is a pivotal moment for stakeholders to engage with a company that's redefining the bio-based product landscape. Stay tuned with Market Unwinded for strategic insights into the burgeoning world of synthetic biology and investment opportunities that redefine market norms. Read More: https://lnkd.in/gT6nHe3T #IzoteBiosciences #SyntheticBiology #BiotechInnovation #VentureCapital #MarketLeadership #SustainableGrowth #MarketUnwinded #InvestmentStrategy #AnaerobicFermentation
To view or add a comment, sign in
-
In #BTS2023 on Biotech Tracking, G.S. Krishnan, President of ABLE - Association of Biotechnology Led Enterprises, introduces the session by underscoring India's role as an innovation hub and manufacturing powerhouse, addressing both domestic and global needs. Emphasizing bioenergy's significance, he discussed the challenges faced by biotech startups in scaling up and calls for strategic support. Today's session explores key themes: bio manufacturing, carbon-free biotechnology, synthetic biology, and sustainable food and agriculture systems. #BreakingBoundaries #TechInnovation #BTS2023
To view or add a comment, sign in
-
Here we are, busy at work with our consortium of scientists and manufacturers. After receiving our grant from Innovate UK, we are putting it to good use. Our heads are spinning from all the potential avenues this project has, all with biotechnology at its core. So exciting seeing such a complex project taking shape and we can’t wait to share more with you! Watch this space. #textilewaste #ESG #ukinnovation #eugreendeal #circulareconomy
To view or add a comment, sign in
451,298 followers
Consultant senior dans les domaines de la Santé et en particulier l'industrie pharmaceutique au niveau mondial.
2wIt's a good job. After for drugs you need clinical trials that could take 10 years and finance. All the big pharmas do it in Boston. USA gets free price for new drugs and become a reference for Europe for EMA and price. Servier decided to get rid off Biogaran. Is it to try to come back to the circle of big pharmas ? The advantage of blockbusters is a high margin and a few people. It's not the case of metoo drugs even if Biogaran is positive but less margin and sale. Like Sanofi you believe to science miracle ? For that you have to believe in god. Anyway if Indians will buy Biogaran they will have the raw materials. So they will have a better margin.